Hakan Gül

Chairman, Conrec Management AB

Klottistelgatan 222 active roles

Hakan Gül holds 2 active roles in Swedish companies registered in Bolagsverket, including Chairman at Conrec Management AB since 2023 and Board of Directors at Miraqle Holding AB since 2022. 1 earlier role has ended, the most recent in 2024.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

Career timeline

2023 – now
Chairman, Conrec Management AB
2023 – 2024
Board of Directors, Conrec Infinity AB
2022 – now
Board of Directors, Miraqle Holding AB

Personal details

Address

Klottistelgatan 22

Companies & roles

Active roles

2 positions

Company	Role	Period	Ownership	Status
Miraqle Holding AB CVR 5594134966	BoardBoard of Directors	Since 2022	—	Active
Conrec Management AB CVR 5594330788	BoardChairman	Since 2023	—	Active

Historical roles

1 positions

Company	Role	Period	Ownership	Status
Conrec Infinity AB CVR 5592134190	BoardBoard of Directors	2023 – 2024	—	Active

Network

Company network

Active roles

Hakan Gül

Past companies

Co-directors & shared companies

Person	Role	Shared companies	Profile
AS Adnan Sorlija	Deputy Board Member	2companies	View profile
HS Hajdar Sorlija	Deputy Board Member	1company	View profile

Is this you? About the data on this page

This profile is compiled automatically from Bolagsverket / SCB, the official business register in Sweden. Riskpilot is operated by Risika A/S, which is the data controller for this page. We don't add private information — only the roles and details the register itself publishes.

Because this is public register data, it can't be erased — corrections to the underlying record are made with the register, and we pick them up once they're published. You do have the right to object to how your details are shown here, and we can de-index this profile so it no longer appears in search engines such as Google.

To make a request, email privacy@risika.com with a link to this page. We respond within 30 days. Read more in our privacy policy.